A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
200
25 mg capsule, every 6 hours
Oral placebo capsule, every 6 hours
Investigative Site
Austin, Texas, United States
Investigative Site
Houston, Texas, United States
Investigative Site
San Marcos, Texas, United States
Investigative Site
Salt Lake City, Utah, United States
Average Numeric Pain Rating Score (NPRS) Over 48 Hours After Bunionectomy
Pain intensity scores were measured using an 11-point numerical pain rating scale (NPRS) with 0=no pain to 10=worst possible pain
Time frame: Over 48 hours after bunionectomy
Number of Patients With Perceptible Pain Relief on Day 1
Times to onset of Perceptible and Meaningful Relief were determined using the double-stopwatch method.
Time frame: 8 hours post single dose
Median Time to Onset of Pain Relief in Patients With Perceptible Pain Relief on Day 1
Time frame: 8 hours post single dose
Number of Patients With Meaningful Pain Relief on Day 1
Times to onset of Perceptible and Meaningful Relief were determined using the double-stopwatch method.
Time frame: 8 hours post single dose
Median Time to Onset of Pain Relief in Patients With Meaningful Pain Relief on Day 1
Time frame: 8 hours post single dose
Total Pain Relief (TOTPAR) Scores 8 Hours Post Initial Dose of Study Drug
Pain relief was rated using a 5-point categorial scale (0=none, 1=a little, 2=some, 3=a lot, and 4=complete) at time of dose (time=0) and over 15 time points afterwards (10, 15, 20, 30, 45, and 60 minutes and at 1.5, 2, 2.5, 3, 4, 5, 6, 7, and 8 hours after the initial dose on Day 1 or until time of re-medication). A score of 0 across all time points would be the lowest (worst) and a score of 60 (4 X 15 time points) would be the highest (best) possible score.
Time frame: 8 hourse post single dose
Number of Patients With at Least 30% Reduction in Pain Intensity After First Dose of Study Drug
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 8 hours post single dose
Time to Onset of at Least 30% Reduction in Pain Intensity After First Dose of Study Drug
Time frame: 8 hours post single dose
Number of Patients Who Required Rescue Medication on Day 1
Time frame: Day 1
Number of Patients Who Required Rescue Medication on Day 2
Time frame: Day 2
Number of Patients Who Required Rescue Medication on Day 3
Day 3 data reflect the use of rescue medication only up to the time of discharge.
Time frame: Day 3